COVID-19 variants of concern, including B.1.1.7, B.1.351, and P.1, encompass mutations facilitating immune evasion. Neutralizing antibody recognition and function may be variably impaired. We considered the impact of mutations on T cell responses. Mutations could be neutral or result in either loss or gain of predicted epitopes depending on HLA type
In late 2020, after circulating for almost a year in the human population, severe acute respiratory ...
We identify amino acid variants within dominant SARS-CoV-2 T cell epitopes by interrogating global s...
We identify amino acid variants within dominant SARS-CoV-2 T cell epitopes by interrogating global s...
The rapid spreading of SARS-CoV-2 variants B.1.1.7 originated from the United Kingdom and B.1.351 fr...
The continual evolution of SARS-CoV-2 and the emergence of variants that show resistance to vaccines...
The massive assessment of immune evasion due to viral mutations that increase COVID-19 susceptibilit...
Although most mutations in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genome a...
We identify amino acid variants within dominant SARS-CoV-2 T cell epitopes by interrogating global s...
As of 25 January 2022, over 349 million individuals have received a confirmed diagnosis of covid-19,...
The accelerated SARS‐CoV‐2 evolution under selective pressure by massive deployment of neutralizing ...
Thesis (Ph.D.)--University of Washington, 2021Since the COVID-19 pandemic began, global sequencing e...
On 24th November 2021, the sequence of a new SARS-CoV-2 viral isolate Omicron-B.1.1.529 was announce...
The current dynamics of the COVID-19 pandemic have become a serious concern with the emergence of a ...
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disclose the variants of concern (V...
The extent to which immune responses to natural infection with severe acute respiratory syndrome cor...
In late 2020, after circulating for almost a year in the human population, severe acute respiratory ...
We identify amino acid variants within dominant SARS-CoV-2 T cell epitopes by interrogating global s...
We identify amino acid variants within dominant SARS-CoV-2 T cell epitopes by interrogating global s...
The rapid spreading of SARS-CoV-2 variants B.1.1.7 originated from the United Kingdom and B.1.351 fr...
The continual evolution of SARS-CoV-2 and the emergence of variants that show resistance to vaccines...
The massive assessment of immune evasion due to viral mutations that increase COVID-19 susceptibilit...
Although most mutations in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genome a...
We identify amino acid variants within dominant SARS-CoV-2 T cell epitopes by interrogating global s...
As of 25 January 2022, over 349 million individuals have received a confirmed diagnosis of covid-19,...
The accelerated SARS‐CoV‐2 evolution under selective pressure by massive deployment of neutralizing ...
Thesis (Ph.D.)--University of Washington, 2021Since the COVID-19 pandemic began, global sequencing e...
On 24th November 2021, the sequence of a new SARS-CoV-2 viral isolate Omicron-B.1.1.529 was announce...
The current dynamics of the COVID-19 pandemic have become a serious concern with the emergence of a ...
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disclose the variants of concern (V...
The extent to which immune responses to natural infection with severe acute respiratory syndrome cor...
In late 2020, after circulating for almost a year in the human population, severe acute respiratory ...
We identify amino acid variants within dominant SARS-CoV-2 T cell epitopes by interrogating global s...
We identify amino acid variants within dominant SARS-CoV-2 T cell epitopes by interrogating global s...